These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1746618)

  • 1. Quantitative analysis of associations between birth defects and suspected human teratogens.
    Khoury MJ; James LM; Lynberg MC
    Am J Med Genet; 1991 Sep; 40(4):500-5. PubMed ID: 1746618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.
    Khoury MJ; Becerra JE; Cordero JF; Erickson JD
    Pediatrics; 1989 Oct; 84(4):658-65. PubMed ID: 2674881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity, specificity, and positive predictive value of multiple malformations in isotretinoin embryopathy surveillance.
    Lynberg MC; Khoury MJ; Lammer EJ; Waller KO; Cordero JF; Erickson JD
    Teratology; 1990 Nov; 42(5):513-9. PubMed ID: 2278026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of dysmorphology in birth defects epidemiology.
    Friedman JM
    Teratology; 1992 Feb; 45(2):187-93. PubMed ID: 1615428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens.
    Khoury MJ; James LM; Flanders WD; Erickson JD
    Teratology; 1992 Jul; 46(1):69-77. PubMed ID: 1641813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the measurement and interpretation of birth defect associations in epidemiologic studies.
    Khoury MJ; James LM; Erickson JD
    Am J Med Genet; 1990 Oct; 37(2):229-36. PubMed ID: 2248290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periconceptional use of weight loss products including ephedra and the association with birth defects.
    Bitsko RH; Reefhuis J; Louik C; Werler M; Feldkamp ML; Waller DK; Frias J; Honein MA;
    Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):553-62. PubMed ID: 18553492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.
    Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P
    Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is a human teratogen: clinical and epidemiological criteria.
    Bertollini R; Pagano M; Mastroiacovo P
    Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection bias and the use of controls with malformations in case-control studies of birth defects.
    Lieff S; Olshan AF; Werler M; Savitz DA; Mitchell AA
    Epidemiology; 1999 May; 10(3):238-41. PubMed ID: 10230831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens.
    Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF
    Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control studies using only malformed infants who were prenatally exposed to drugs. What do the results mean?
    Prieto L; Martínez-Frías ML
    Teratology; 2000 Jul; 62(1):5-9. PubMed ID: 10861626
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital malformations related to occupational reproductive hazards.
    Sever LE
    Occup Med; 1994; 9(3):471-94. PubMed ID: 7831593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth defects among infants born to women who received anthrax vaccine in pregnancy.
    Ryan MA; Smith TC; Sevick CJ; Honner WK; Loach RA; Moore CA; Erickson JD
    Am J Epidemiol; 2008 Aug; 168(4):434-42. PubMed ID: 18599489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic methods in the search for causes of human birth defects.
    Ferencz C; Loffredo C; Wilson PD
    Teratology; 2000 Apr; 61(4):243-5. PubMed ID: 10716741
    [No Abstract]   [Full Text] [Related]  

  • 20. Cocaine and single ventricle: a population study.
    Martin ML; Khoury MJ
    Teratology; 1992 Sep; 46(3):267-70. PubMed ID: 1523584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.